Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
5.26
-0.25 (-4.63%)
At close: Sep 11, 2026, 4:00 PM EDT
5.32
+0.07 (1.24%)
After-hours: Sep 11, 2026, 7:43 PM EDT
Aclaris Therapeutics Market Cap
Aclaris Therapeutics has a market cap or net worth of $783.1 million as of September 11, 2026. Its market cap has increased by 254.35% in one year.
Market Cap
783.10M
Enterprise Value
614.33M
1-Year Change
254.35%
Ranking
Category
Stock Price
$5.26
ChartMarket Cap Chart
Since October 7, 2015, Aclaris Therapeutics's market cap has increased from $214.45M to $783.10M, an increase of 265.16%. That is a compound annual growth rate of 12.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 783.10M | 140.13% |
| Dec 31, 2025 | 326.12M | 22.88% |
| Dec 31, 2024 | 265.41M | 256.83% |
| Dec 29, 2023 | 74.38M | -92.92% |
| Dec 30, 2022 | 1.05B | 17.97% |
| Dec 31, 2021 | 890.25M | 220.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Geron | 880.19M |
| Candel Therapeutics | 866.96M |
| Climb Bio | 858.67M |
| Crescent Biopharma | 832.91M |
| Silence Therapeutics | 801.39M |
| Annexon | 784.86M |
| DBV Technologies | 779.01M |
| MapLight Therapeutics | 766.11M |